title: Dendritic cell-based immunotherapy in ovarian cancer.
abstract: Worldwide, 80% of patients with ovarian cancer die of the disease. New treatments for this aggressive disease are therefore being intensively searched. Although dendritic cell-based vaccines against gynecological malignancies are in their infancy, this immunotherapeutic approach holds much promise. Here, we present our view on an optimal dendritic cell-based immunotherapeutic strategy against ovarian cancer.
authors: Department of Gynecologic Oncology; Leuven Cancer Institute, KU Leuven, Belgium.
authors: An
authors: A
authors: Coosemans
authors: Department of Gynecologic Oncology; Leuven Cancer Institute, KU Leuven, Belgium.
authors: Ignace
authors: I
authors: Vergote
authors: Department of Microbiology and Immunology; KU Leuven, Belgium.
authors: Stefaan W
authors: SW
authors: Van Gool
keywords: DC; DC immunotherapy; WT1; dendritic cell; ovarian cancer